A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours

Madhuri Kalathur, Alberto Toso, Jingjing Chen, Ajinkya Revandkar, Claudia Danzer-Baltzer, Ilaria Guccini, Abdullah Alajati, Manuela Sarti, Sandra Pinton, Lara Brambilla, Diletta Di Mitri, Giuseppina Carbone, R. Garcia-Escudero, Alessandro Padova, Letizia Magnoni, Alessia Tarditi, Laura Maccari, Federico Malusa, Ravi Kiran Reddy Kalathur, Lorenzo A. PinnaGiorgio Cozza, Maria Ruzzene, Nicolas Delaleu, Carlo V. Catapano, Ian J. Frew, Andrea Alimonti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences

Chemical Compounds